These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21122582

  • 1. Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis.
    Van Hauwaert V, Meers S, Verhoef G, Tousseyn T, Sagaert X, Vermeire S, Rutgeerts P, Van Assche G.
    J Crohns Colitis; 2010 Dec; 4(6):683-6. PubMed ID: 21122582
    [Abstract] [Full Text] [Related]

  • 2. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
    Chaparro M, Trapero-Marugán M, Guijarro M, López C, Moreno-Otero R, Gisbert JP.
    J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
    [Abstract] [Full Text] [Related]

  • 3. [Rectal diffuse large B cell lymphoma appearing after immunosuppression for ulcerative colitis. Report of one case].
    Quera R, Flores L, Simian D, Kronberg U, Vial MT, de Guevara DL, García-Rodríguez MJ.
    Rev Med Chil; 2017 Oct; 145(10):1342-1348. PubMed ID: 29488576
    [Abstract] [Full Text] [Related]

  • 4. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U.
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [Abstract] [Full Text] [Related]

  • 5. Rectal lymphoma in ulcerative colitis treated with azathioprine.
    Tan CW, Wilson GE, Howat JM, Shreeve DR.
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):989-92. PubMed ID: 11507370
    [Abstract] [Full Text] [Related]

  • 6. Infliximab for ulcerative colitis following liver transplantation.
    Lal S, Steinhart AH.
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
    [Abstract] [Full Text] [Related]

  • 7. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U, Kochhar G, Venkatesh PG, Bennett AE, Rizk M, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [Abstract] [Full Text] [Related]

  • 8. Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood.
    Cardile S, Candusso M, Papadatou B, Bracci F, Knafelz D, Torre G.
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):736. PubMed ID: 28441268
    [No Abstract] [Full Text] [Related]

  • 9. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab.
    Duca I, Ramírez de la Piscina P, Estrada S, Calderón R, Spicakova K, Urtasun L, Marra-López C, Zabaleta S, Bengoa R, Marcaide MA, García-Campos F.
    World J Gastroenterol; 2013 Jan 28; 19(4):590-3. PubMed ID: 23382642
    [Abstract] [Full Text] [Related]

  • 10. Colitis-associated sclerosing cholangitis in children: a single centre experience.
    Noble-Jamieson G, Heuschkel RB, Torrente F, Hadzic N, Zilbauer M.
    J Crohns Colitis; 2013 Nov 28; 7(10):e414-8. PubMed ID: 23485432
    [Abstract] [Full Text] [Related]

  • 11. A review of infliximab use in ulcerative colitis.
    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.
    Clin Ther; 2008 Feb 28; 30(2):223-30. PubMed ID: 18343261
    [Abstract] [Full Text] [Related]

  • 12. Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.
    Tse CS, Loftus EV, Raffals LE, Gossard AA, Lightner AL.
    Aliment Pharmacol Ther; 2018 Jul 28; 48(2):190-195. PubMed ID: 29808485
    [Abstract] [Full Text] [Related]

  • 13. Mucin-producing carcinoma of the gallbladder associated with primary sclerosing cholangitis and ulcerative colitis.
    Noda H, Chiba F, Toyama N, Konishi F.
    J Hepatobiliary Pancreat Surg; 2009 Jul 28; 16(1):83-5. PubMed ID: 19096754
    [Abstract] [Full Text] [Related]

  • 14. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U, Venkatesh PG, Lashner BA, Remzi FH, Shen B, Kiran RP.
    J Crohns Colitis; 2012 Sep 28; 6(8):845-51. PubMed ID: 22398080
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.
    Komatsu K, Shimosegawa T, Kikuchi S, Uchi M, Maruhama Y, Kisara N, Ueno Y, Toyota T.
    Intern Med; 2000 Dec 28; 39(12):1049-53. PubMed ID: 11197788
    [Abstract] [Full Text] [Related]

  • 16. Diffuse gastroduodenitis associated with ulcerative colitis: treatment by infliximab.
    Chiba M, Ono I, Wakamatsu H, Wada I, Suzuki K.
    Dig Endosc; 2013 Nov 28; 25(6):622-5. PubMed ID: 24164601
    [Abstract] [Full Text] [Related]

  • 17. Development of testicular germ cell cancer following successful infliximab induction therapy for ulcerative colitis.
    Wong JC, Bressler B, Salh B, Yoshida EM, Chatur N.
    J Crohns Colitis; 2011 Apr 28; 5(2):162-4. PubMed ID: 21453887
    [Abstract] [Full Text] [Related]

  • 18. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
    Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ.
    Gastroenterology; 2011 Oct 28; 141(4):1194-201. PubMed ID: 21723220
    [Abstract] [Full Text] [Related]

  • 19. Effective use of switching biologics for ulcerative colitis complicated with pyoderma gangrenosum and primary sclerosing cholangitis.
    Iwahashi K, Kuroki Y, Takano Y, Nagahama M.
    BMJ Case Rep; 2021 May 06; 14(5):. PubMed ID: 33958364
    [Abstract] [Full Text] [Related]

  • 20. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK, Uzcanga LF.
    Dig Surg; 2008 May 06; 25(5):383-6. PubMed ID: 19005257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.